Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 04-2009 | 01-2009 | 10-2008 | 07-2008 | 04-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -16,517 | -8,160 | -4,248 | N/A |
| Depreciation Amortization | N/A | 91 | 51 | 33 | N/A |
| Accounts receivable | N/A | -125 | 4 | -31 | N/A |
| Other Working Capital | N/A | -335 | -243 | 175 | N/A |
| Other Operating Activity | 0 | 14,166 | 6,585 | 3,197 | 0 |
| Operating Cash Flow | $N/A | $-2,720 | $-1,764 | $-874 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -89 | -24 | -14 | N/A |
| Purchase Sale Intangibles | N/A | -171 | -70 | -20 | N/A |
| Other Investing Activity | 0 | -171 | -70 | -20 | 0 |
| Investing Cash Flow | $N/A | $-260 | $-94 | $-34 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 20 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 2,226 | 2,226 | 2,148 | N/A |
| Other Financing Activity | 0 | 0 | -44 | -33 | 0 |
| Financing Cash Flow | $N/A | $2,246 | $2,182 | $2,115 | $N/A |
| Beginning Cash Position | N/A | 4,881 | 4,881 | 4,881 | N/A |
| End Cash Position | N/A | 4,146 | 5,205 | 6,088 | N/A |
| Net Cash Flow | $N/A | $-735 | $324 | $1,207 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -2,720 | -1,764 | -874 | N/A |
| Capital Expenditure | N/A | -89 | -24 | -14 | N/A |
| Free Cash Flow | 0 | -2,810 | -1,788 | -888 | 0 |